Fibrotic Diseases Treatment Market – The Rise of Targeted and Precision Therapies
The fibrotic diseases treatment market is undergoing a paradigm shift as molecular profiling and precision medicine reshape therapeutic approaches. Historically managed with broad-spectrum antifibrotics and immunosuppressants, fibrotic conditions are now being approached with a deeper understanding of their genetic and molecular drivers, such as TGF-β signaling, Wnt pathways, and...
0 Comments 0 Shares 78 Views 0 Reviews